Lifecore Biomedical, Inc. \De\ financial data

Symbol
LFCR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3515 Lyman Boulevard, Chaska, MN
State of incorporation
DE
Fiscal year end
May 25
Former names
LANDEC CORP \CA\ (to 11/7/2022)
Latest financial report
10-Q - Q1 2025 - Apr 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 220 % +1.48%
Quick Ratio 107 % -1.13%
Debt-to-equity 3.17K % -95%
Return On Assets -18 % -121%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37M shares +21.2%
Common Stock, Shares, Outstanding 37M shares +21.2%
Entity Public Float 154M USD -15%
Common Stock, Value, Issued 37K USD +23.3%
Weighted Average Number of Shares Outstanding, Basic 37M shares +21.4%
Weighted Average Number of Shares Outstanding, Diluted 37M shares +1.12%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.32M USD -2.49%
Operating Income (Loss) -20.4M USD -15.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44.7M USD -122%
Income Tax Expense (Benefit) -47K USD -110%
Net Income (Loss) Attributable to Parent -44.7M USD -121%
Earnings Per Share, Basic -1.48 USD/shares -114%
Earnings Per Share, Diluted -1.39 USD/shares -61.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.42M USD
Accounts Receivable, after Allowance for Credit Loss, Current 30.3M USD
Inventory, Net 34.6M USD -12.8%
Assets, Current 84.2M USD +10.6%
Property, Plant and Equipment, Net 128M USD -11.8%
Operating Lease, Right-of-Use Asset 2.23M USD -11%
Intangible Assets, Net (Excluding Goodwill) 4.2M USD 0%
Goodwill 13.9M USD 0%
Other Assets, Noncurrent 4.95M USD +19.9%
Assets 238M USD -3.47%
Accounts Payable, Current 7.41M USD -52.8%
Employee-related Liabilities, Current 5.84M USD +43.6%
Accrued Liabilities, Current 19.7M USD
Contract with Customer, Liability, Current 2.57M USD -19.8%
Liabilities, Current 31.1M USD -15.5%
Contract with Customer, Liability, Noncurrent 4.42M USD
Deferred Income Tax Liabilities, Net 552K USD +32.7%
Operating Lease, Liability, Noncurrent 1.44M USD
Other Liabilities, Noncurrent 9.81M USD +94.1%
Liabilities 190M USD +1.85%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -204M USD -28%
Stockholders' Equity Attributable to Parent 2.23M USD -87.4%
Liabilities and Equity 238M USD -3.47%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -643K USD +92.3%
Net Cash Provided by (Used in) Financing Activities 1.09M USD -62.7%
Net Cash Provided by (Used in) Investing Activities -3.39M USD +32.9%
Common Stock, Shares Authorized 75M shares +50%
Common Stock, Shares, Issued 37M shares +21.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.94M USD +71.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.42M USD +76.3%
Deferred Tax Assets, Valuation Allowance 46.2M USD -12.1%
Deferred Tax Assets, Gross 65.9M USD -0.68%
Operating Lease, Liability 5.4M USD
Payments to Acquire Property, Plant, and Equipment 3.39M USD -32.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12M USD +82%
Lessee, Operating Lease, Liability, to be Paid 5.57M USD
Property, Plant and Equipment, Gross 184M USD
Operating Lease, Liability, Current 3.97M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 416K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 433K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 166K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 302K USD
Deferred Tax Assets, Operating Loss Carryforwards 40.8M USD -8.54%
Preferred Stock, Shares Issued 44.1K shares +7.48%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 1.27M USD +8.36%
Lessee, Operating Lease, Liability, to be Paid, Year Four 146K USD
Additional Paid in Capital 206M USD +16.5%
Preferred Stock, Shares Outstanding 44.1K shares +7.48%
Depreciation, Depletion and Amortization 1.99M USD -8.07%
Deferred Tax Assets, Net of Valuation Allowance 19.7M USD +42.5%
Share-based Payment Arrangement, Expense 8.88M USD +84.1%
Interest Expense 17.6M USD +13.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%